The University of Arizona

Applications for Submission

Report Misconduct

University Ethics and Compliance Hotline:

866-364-1908

HSPP Contacts

Department email:
VPR-IRB@email.arizona.edu

*Subscribe to the HSPP listserv

Mariette Marsh, Director
(520) 626-7575

Mason Burchfield, IRB Coordinator
(520) 626-0433

Gina Fimbres, IRB Associate
(520) 626-0026

Jared Pryor, IRB Associate
(520) 626-1744

Jessica Winters, IRB Associate
(520) 626-0256

Street Address
1618 E. Helen Street
Tucson, AZ 85721

Mailing Address
POB 210409
Tucson, AZ 85721


HOW ARE WE DOING?

Customer Service Survey


 

The New Common Rule has been delayed until January 21, 2019. To see how the UA will implement the new rules please click here.

Applications for Review

If you are having trouble getting the forms to download outside of your web browser please read these instructions here.

Determination of Human Research (PDF)
The Determination of Human Research form should be used when it is unclear if the proposed activities require review by an Institutional Review Board (IRB). If the proposed study clearly is Human Research, do not complete this form! Instead, please submit the appropriate application for review and approval by the IRB. The Human Subjects Protection Program will provide a written determination which can be used to provide sponsors, collaborators, journal editors, and others with verification from an impartial source as to whether or not the proposed activities require IRB approval.

Application for Human Research (PDF)
Application for review of a proposed study involving collection of data from or interaction with human subjects, study involving existing records review, data abstraction, and analysis and requests that IRB oversight be deferred to a non-University of Arizona IRB.

Request for University of Arizona Human Research Site Authorization (RedCap)
Request for investigators who are not affiliated with the University of Arizona to access University resources to conduct human research. See UA Site Authorization for guidance.

Appendices

Appendix for Vulnerable Populations (PDF)
This form should be used when children/wards, Prisoners, Native American or Indigenous Research and Pregnant Woman and Neonates are engaged in the research.

Appendix for Devices (PDF)
This form should be used when the Human Research is a clinical investigation of a device which is "any experiment that involves a test article on one or more human subjects that either (1) requires FDA approval, or (2) is intended to be submitted to or inspected by the FDA for research or a marketing permit." (21 CFR 50.3(c)(link is external))

Appendix for Drugs (PDF)

This form should be used when the Human Research is a clinical investigation of a drug, which is "any experiment that involves a test article on one or more human subjects that either (1) requires FDA approval, or (2) is intended to be submitted to or inspected by the FDA for research or a marketing permit." (21 CFR 50.3(c)(link is external))

Appendix for Alterations/Waivers of Consent or PHI (PDF)
This form is used when a waiver of informed consent, alteration of consent, or alteration or waiver of protected health information (PHI) is needed.

Appendix for Exceptions from Informed Consent (EFIC) (PDF)
This form is used when an exception from informed consent is needed.

Renewals

Renewal/Closure for Human Subjects (PDF)
All non-exempt Human Research must receive IRB review and approval at intervals appropriate to the degree of risk, but not less often than once a year

  •  Renewals submitted more than 45 calendar days prior to the project's expiration date will be reviewed and approved as soon as possible after receipt and the project will be given a new period of approval with a new expiration date.
  • Renewals submitted 45-30 calendar days prior to expiration will be reviewed as normal, maintaining the same period of approval and expiration date.
  • Renewals submitted within 30 calendar days of the project's expiration date are not guaranteed review or approval by the project's expiration date. If the project is not reapproved by its expiration date, it will be administratively closed

Investigators are responsible for concluding human research activities as soon as possible after a project if completed and/or no longer involves human subjects. Projects not concluded after the expiration date of the project are considered administratively closed by HSPP.

See Concluding Human Research and Administrative Closures for guidance.

Amendments and Reportables

Amendment to Approved Human Research (PDF)

  • This form is used to request approval to an amendment of previous approved human subject research.
  • For minor amendments (typographical errors, updates to contact information, etc.).
  • When there is change to the project personnel.
  • To notify the IRB when there are items that need to be acknowledged.
  • Used to report information (events) that may be problematic to the conduct of the research to the IRB. See the Adverse Events Flowchart for information.

See Amending Approved Research for guidance.

Additional Forms

List of Research Personnel (PDF)
Senior/Key personnel, as defined by the National Institutes of Health, must be included on the list and have current CITI training before they may conduct any activities related to the human research.

The HSPP requires that the List of Research Personnel also include information on:

  • Any person consenting subjects
  • Any person with access to identifiable data
  • Faculty advisors for student research
  • Study coordinator/contact person

External Site Authorization (Word)
External Site Authorization approval, in the form of an authorization letter, is required from a site external to the University of Arizona if a University employee or student will be conducting research at that external site. The letter must be on file with the IRB prior to conducting research at the external site.

The authorization letter must include:

  1. The investigator’s name and title, the title of the research protocol, and a brief summary of the protocol to confirm site understanding of the study.
  2. A statement that the site will receive a copy of the IRB-approved, stamped consent document.
  3. A definition as to whether the investigator or their staff will contact and/or recruit employees and if permission is granted to collect data at the location.
  4. A statement explaining what the site has agreed to allow the investigator or their staff to do, including any restriction or limitations and what responsibilities, if any, the site is assuming.
  5. A statement as to whether or not the site will receive any benefits, including a copy of any aggregate results.
  6. The time frame involved or any time restrictions.

The authorization letter must be on company letterhead and include the title and signature of the company representative giving the authorization.

HSPP has provided a template to assist you in drafting the authorization letter. 

Institutional Certification for NIH Genomic Data Sharing (Word)
The National Institutes of Health (NIH) issued the Genomic Data Sharing (GDS) policy(link is external) to ensure the broad and responsible sharing of genomic research data. This policy applies to all NIH-funded research that generates large-scale human or non-human genomic data as well as the use of these data for subsequent research. See the NIH's Supplemental Information to the National Institutes of Health Genomic Data Sharing Policy(link is external) for a summary of the policy.
Certification from a University of Arizona Organizational Official is required before an investigator can submit materials as required by the GDS policy. Complete the Institutional Certification for NIH Genomic Data Sharing and submit to HSPP for signature.

See HSPP's NIH Genomic Data Sharing for NIH Grant Submission for guidance.